Page 6 - Prtk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Prtk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Prtk Today - Breaking & Trending Today
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero purchased 105,137 shares of the firm’s stock in a transaction on Monday, March 20th. The stock was bought at an average price of $1.40 per share, for a total transaction of $147,191.80. Following the completion of the transaction, the insider now directly owns […] ....
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero bought 106,000 shares of the business’s stock in a transaction on Wednesday, March 22nd. The shares were acquired at an average cost of $1.77 per share, for a total transaction of $187,620.00. Following the purchase, the insider now directly owns 2,056,000 shares in […] ....
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its target price lowered by HC Wainwright from $20.00 to $10.00 in a research report sent to investors on Monday morning, The Fly reports. HC Wainwright also issued estimates for Paratek Pharmaceuticals’ Q1 2023 earnings at ($0.27) EPS, Q2 2023 earnings at ($0.24) EPS, Q3 2023 earnings at […] ....
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) – Equities researchers at HC Wainwright lowered their Q1 2023 earnings estimates for Paratek Pharmaceuticals in a report issued on Monday, March 20th. HC Wainwright analyst E. Arce now forecasts that the specialty pharmaceutical company will post earnings per share of ($0.27) for the quarter, down from their […] ....
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) and IMV (NASDAQ:IMV – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations. Analyst Ratings This is a breakdown of current ratings and […] ....